CN111920911B - 一种防蚊消毒剂及制备方法 - Google Patents
一种防蚊消毒剂及制备方法 Download PDFInfo
- Publication number
- CN111920911B CN111920911B CN202010648737.XA CN202010648737A CN111920911B CN 111920911 B CN111920911 B CN 111920911B CN 202010648737 A CN202010648737 A CN 202010648737A CN 111920911 B CN111920911 B CN 111920911B
- Authority
- CN
- China
- Prior art keywords
- parts
- mosquito
- vitamin
- disinfectant
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000645 desinfectant Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 43
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229960002152 chlorhexidine acetate Drugs 0.000 claims abstract description 21
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229960000907 methylthioninium chloride Drugs 0.000 claims abstract description 17
- 241001071917 Lithospermum Species 0.000 claims abstract description 16
- 239000000341 volatile oil Substances 0.000 claims abstract description 16
- 244000166675 Cymbopogon nardus Species 0.000 claims abstract description 15
- 235000018791 Cymbopogon nardus Nutrition 0.000 claims abstract description 15
- 239000010677 tea tree oil Substances 0.000 claims abstract description 15
- 229940111630 tea tree oil Drugs 0.000 claims abstract description 15
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 claims abstract description 14
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 12
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 12
- 229940046009 vitamin E Drugs 0.000 claims abstract description 12
- 239000011709 vitamin E Substances 0.000 claims abstract description 12
- 229920000136 polysorbate Polymers 0.000 claims abstract description 11
- 230000001442 anti-mosquito Effects 0.000 claims abstract description 6
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229930003571 Vitamin B5 Natural products 0.000 claims abstract description 4
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims abstract description 4
- 229960002079 calcium pantothenate Drugs 0.000 claims abstract description 4
- 235000009492 vitamin B5 Nutrition 0.000 claims abstract description 4
- 239000011675 vitamin B5 Substances 0.000 claims abstract description 4
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 claims abstract 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 19
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 17
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 17
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 12
- 235000019441 ethanol Nutrition 0.000 claims description 7
- 239000000077 insect repellent Substances 0.000 claims description 7
- 229930003270 Vitamin B Natural products 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 235000019156 vitamin B Nutrition 0.000 claims description 6
- 239000011720 vitamin B Substances 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 4
- 229920000053 polysorbate 80 Polymers 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 2
- 229910021641 deionized water Inorganic materials 0.000 claims description 2
- 230000001804 emulsifying effect Effects 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims description 2
- 208000003251 Pruritus Diseases 0.000 abstract description 9
- 206010003399 Arthropod bite Diseases 0.000 abstract description 7
- XOSXWYQMOYSSKB-LDKJGXKFSA-L water blue Chemical compound CC1=CC(/C(\C(C=C2)=CC=C2NC(C=C2)=CC=C2S([O-])(=O)=O)=C(\C=C2)/C=C/C\2=N\C(C=C2)=CC=C2S([O-])(=O)=O)=CC(S(O)(=O)=O)=C1N.[Na+].[Na+] XOSXWYQMOYSSKB-LDKJGXKFSA-L 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 27
- 238000004659 sterilization and disinfection Methods 0.000 description 18
- XQAXGZLFSSPBMK-UHFFFAOYSA-M [7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride;trihydrate Chemical compound O.O.O.[Cl-].C1=CC(=[N+](C)C)C=C2SC3=CC(N(C)C)=CC=C3N=C21 XQAXGZLFSSPBMK-UHFFFAOYSA-M 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 241000255925 Diptera Species 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 150000003722 vitamin derivatives Chemical class 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 241000282414 Homo sapiens Species 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 230000003385 bacteriostatic effect Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 4
- 235000019796 monopotassium phosphate Nutrition 0.000 description 4
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 230000001846 repelling effect Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 241000256173 Aedes albopictus Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000000022 bacteriostatic agent Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010058679 Skin oedema Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 241000191984 Staphylococcus haemolyticus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 238000013095 identification testing Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pest Control & Pesticides (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明提供一种防蚊消毒剂及制备方法,主要由醋酸氯己定、维生素B5、紫草提取物、薰衣草油、香茅精油、茶树油、维生素E、无水乙醇、甘油、吐温、水、亚甲基蓝组成,本发明无皮肤刺激性,适用于局部抑菌消毒,能有效地杀死皮肤上各种细菌,有害微生物。同时还可以有效防止蚊虫叮咬,可以缓解蚊虫叮咬后的不适,能够消除蚊虫叮咬后的瘙痒。
Description
技术领域
本发明提供一种皮肤损伤抑菌消毒剂及制备方法,能有效地杀死皮肤上各种细菌,有害微生物。并可有效防止蚊虫叮咬,能够消除蚊虫叮咬后的瘙痒,属于消毒剂技术领域。
背景技术
随着科学技术的发展,针对患者和接触患者人员的消毒已成为切断传染途径的必要措施。但是传统消毒剂通常具有一定毒性和残留。长期使用会对人和动物产生不同程度的伤害,并且对环境造成严重污染。所以,配制一种安全高效的消毒剂,对于预防干预环境卫生非常重要。特别是城市化速度加快造成的人群大量聚集,必然会使生命体不可避免地受到各种各样的环境影响,这些影响包括宇宙射线太阳光紫外线射线,寄居昆虫,环境中的微生物,病毒等。
国内临床常用的抑菌剂是醋酸氯己定。国内逾70年代初期开始将醋酸氯己定,尝试用于手术人员的泡手,消毒器械消毒等。
但是传统的醋酸氯己定溶液具有,配制困难,携带不便的缺点。因为常常配制成水溶液使用,用于人体时部分位置不易作用到,并且溶液容易挥发流失,抑菌时效性短。不适宜野外作业人群的使用。
高温高湿环境中滋生的蚊虫,给人类带来滋扰伤害和生命威胁,还会引起诸如影响睡眠,传播疾病等不利因素,尤其是叮咬过后引起的瘙痒。
瘙痒是皮肤或粘膜的一种引起搔抓欲望的不愉快的感觉。抑制减轻叮咬后的瘙痒不但可以减轻皮肤的不适,还可以减少瘙痒搔抓引起的皮肤损伤和继发性感染。
传统消毒剂酒精碘伏,对皮肤黏膜无损撞伤具有明显的消毒作用,尤其对皮肤创伤伤口具有消毒作用,但是由于具有一定刺激作用和残留,所以适用性较差。
综上所述,人们对安全无毒无副作用的皮肤粘膜抑菌消毒剂存在着极大的需求。尤其是处于高温高湿环境中的野外作业人群,室外活动人群。
本发明不但适用于局部抑菌消毒,较传统消毒,无刺激性和抑菌毒副作用的特点,还可以有效防止蚊虫叮咬,可以缓解蚊虫叮咬后的不适。
发明内容
人们对安全,无毒副作用的消毒液存在着极大的需求,尤其对于高温高湿环境中暴露于滋生蚊虫的野外作业人群、室外活动人群。对具有皮肤消毒,防蚊驱蚊,抑制瘙痒功能的产品有强烈的使用欲望。申请人经过大量的研究试验,成功地研制出一种防蚊消毒剂。
本发明所述的防蚊消毒剂的组合物。制备用于皮肤消毒,防蚊驱蚊,抑制瘙痒等用途。
本发明解决其技术问题所采用的技术方案是,提供一种防蚊消毒剂,其特征是:醋酸氯己定1~2份;维生素B5 2~4份;紫草提取物10~20份;薰衣草油5~10份;香茅精油1~2份;茶树油1~2份;维生素E 10~20份;无水乙醇 80~160份;甘油 60~120份;吐温80 10~20份;水800~1600份;亚甲基蓝0.008~0.016份;HPMC 20~40份混合均匀即得。
作为优选,所述的防蚊消毒剂,其特征是醋酸氯己定1份;维生素B5 2份;紫草提取物10份;薰衣草油5份;香茅精油1份;茶树油1份;维生素E 10份;无水乙醇 80份;甘油 60份;吐温80 10份;水800份;亚甲基蓝0.01份;HPMC 20份。
所述醋酸氯己定,CAS号: 56-95-1;
所述紫草提取物,CAS号: 517-89-5;
所述薰衣草油,CAS号: 8000-28-0;
所述香茅精油,CAS号: 73049-78-2;
所述茶树油,CAS号: 68647-73-4;
所述维生素E,CAS号: 1406-66-2;
所述维生素B5,CAS号:79-83-4;
所述无水乙醇,CAS号:64-17-5;
所述甘油,CAS号:56-81-5;
所述吐温80,CAS号:9005-65-6;
所述HPMC,CAS号:9004-65-3;
所述亚甲基蓝,CAS号:7220-79-3。
作为优选,所述的防蚊消毒剂,其特征是:所述的紫草提取物规格为水蒸馏法10:1
作为优选,所述的防蚊消毒剂,其特征是:所述的香茅精油规格为水蒸馏法含香茅醛不低于85%。
作为优选,所述的防蚊消毒剂,其特征是:所述的薰衣草油规格为水蒸馏法含挥发油不低于99%
作为优选,所述的防蚊消毒剂,其特征是:所述的茶树油规格为水蒸馏法含4-松油烯醇不低于33 %
作为优选,所述的防蚊消毒剂,其特征是由下述方法制备:
1)先在搅拌锅里加入去离子水,称量处方量亚甲基蓝溶液,加入醋酸氯己定、维生素B5 g搅拌至溶解,配成水相;
2)称量处方量甘油、无水乙醇、吐温80、紫草提取物、茶树油、香茅精油、薰衣草油、VE搅拌至溶解,配成醇相;
3)称取处方量HPMC,加入搅拌中的醇相,搅拌15分钟;
4)将水相经过过滤后加入搅拌中的醇相,持续15分钟;
5)搅拌混合样品经过-0.07Mpa真空乳化1小时,过滤灌装即为成品。
本发明积极效果在于本发明具有延缓释放驱蚊剂的效果,能在长时间内保持驱蚊效果,通过降低渗透速率,以达到驱蚊止痒而又不刺激皮肤的效果,避免了对皮肤产生刺激性的影响,提高了使用的舒适感,而且通过将亚甲基蓝与紫草提取的复配使用,改变产品色泽,更易于使用人群接受,同时亚甲基蓝提高了消毒成分的回收率,延长了产品的货架期,提高了杀菌效果。
以下通过实施例形式再对本发明的内容作进一步详细说明,但不应就此理解为本发明上述主题范围内仅限于以下实施例。在不脱离本发明上述技术前提下,根据本领域普通技术知识和惯用手段做出的相应替换或变更的修改,均包括在本发明的范围内。
实施例1
批号:20200310-1。醋酸氯己定1.00g;维生素B5 2.32g;紫草提取物10.01g;薰衣草油4.93g;香茅精油1.02g;茶树油1.08g;维生素E 9.84g;无水乙醇 79.37g;甘油60.31g;吐温80 9.85g;10ppm亚甲基蓝溶液798.74g;HPMC 20.55g混合均匀即得。
实施例2
批号:20200310-2。醋酸氯己定1.00 g;维生素B5 2.44g;紫草提取物10.18g;薰衣草油5.24g;香茅精油1.10g;茶树油0.92g;维生素E 11.15g;无水乙醇80.19g;甘油62.42g;吐温80 11.17g;6ppm的亚甲基蓝溶液790.54g;HPMC 20.03g混合均匀即得。
实施例3
批号:20200310-3。醋酸氯己定1.00g;维生素B5 2.01g;紫草提取物10.45g;薰衣草油4.96g;香茅精油1.05g;茶树油1.02g;维生素E 10.74g;无水乙醇80.22g;甘油60.26g;吐温80 10.55g;2ppm的亚甲基蓝溶液793.30g; HPMC 20.02g混合均匀即得。
实施例4
批号:20200310-4醋酸氯己定1.00g;维生素B5 1.88g;紫草提取物10.66g;薰衣草油5.00g;香茅精油0.98g;茶树油1.02g;维生素E 10.01g;无水乙醇80.20g;甘油62.34g;吐温80 10.28g;纯化水802.18g; HPMC 19.98g混合均匀即得。
实施例5
批号:20200313-1。醋酸氯己定10g;维生素B5 21g;紫草提取物101g;薰衣草油50g;香茅精油10g;茶树油10g;维生素E 102g;无水乙醇814g;甘油619g;吐温80 101g;纯化水7990g; HPMC 199g混合均匀即得。
实施例6
批号:20200313-2。醋酸氯己定10g;维生素B5 22g;紫草提取物98g;薰衣草油55g;香茅精油12g;茶树油14g;维生素E 103g;无水乙醇820g;甘油596g;吐温80 100g;纯化水8060g; HPMC 200g混合均匀即得。
通过以下试验进一步表明本发明消毒凝胶的抑菌消毒作用。
试验1:有效成分的测定
试验样品:醋酸氯己定;
批号:20200310-1,20200310-2,20200310-3,20200310-4,20200313-1,20200313-2
试剂:乙腈,磷酸,磷酸二氢钾溶液
仪器:1,天平,2,pH计,3高效液相色谱仪
色谱条件:流动相:磷酸二氢钾:乙腈=650:350;柱温,30℃、检测波长:254nm、进样量:10ul、色谱柱:C18柱(150mm×4.6mm ×5μm)、流量:1.0 ml /min。
结果:见表1。
结论:上述6个批号的消毒成分含量测定均超过80%。其配方中含有亚甲基蓝的处方,消毒成分含量均超过90%,实验结果显示,亚甲蓝成分对消毒成分回收率提高有明显促进作用。
试验2:皮肤消毒试验
一、器材
1、试验样品:20200313-2;
2、中和剂:D/E肉汤;
3、其他:灭菌棉签,含0.1%吐温80的PBS等。
二、方法
1、检测依据:中和剂鉴定试验和消毒剂对皮肤消毒现场试验按照卫生部《消毒技术规范》(2002版)2.1.1.5.5条和2.1.2.8条。
2、现场试验受试部位及数量:受试者左右前臂内侧中段皮肤。受试数量:30人次。
3、消毒处理方法:取样品原液涂擦在右手前臂内侧中段皮肤2次,2min后采样,结果见表2。
肤,作用时间为2min,对皮肤的自然菌的平均灭除对数值>1.0。
试验3:微生物学指标
一、器材
1、试验样品:抑菌凝胶,批号20200313-2;
2、仪器设备:KC-SP-YQ-013生化培养箱、KC-SP-YQ-082霉菌培养箱。
二、方法
1、检测温度20℃,相对湿度53%;
2、样品处理:原样。
三、结果
批号批号20200313-2原样的细菌菌落总数、真菌菌落总数<4CFU/g,大肠杆菌、金黄色葡萄球菌、绿脓杆菌、溶血性链球菌均未检出,结果列于表3。
四、结论
批号批号20200313-2原样的细菌菌落总数、真菌菌落总数<4CFU/g,大肠杆菌、金黄色葡萄球菌、绿脓杆菌、溶血性链球菌均未检出。
试验4抑菌性能实验
一、器材
试验样品:批号20200313-2;
实验菌株:金黄色葡萄球菌CMCC(B)26003、大肠杆菌CMCC(B)44102、白色念珠菌CMCC(F)98001,均取其第五代新鲜斜面培养物进行实验,由中国医学细菌保藏管理中心提供;
仪器设备:GHP-9270N生化培养箱。
二、方法
检测温度21~23℃,相对湿度51%~53%。
样品处理:原样。
一、结果
批号批号20200310-1作用20min对金黄色葡萄球菌、大肠杆菌、白色念珠菌的抑菌率数据分别用表4、表5、表6列出。
四、结论
批号20200313-2原样作用20min对金黄色葡萄球菌的平均抑菌率为99.97%,有较强抑菌作用;对大肠杆菌的平均抑菌率为99.97%,有较强抑菌作用;对白色念珠菌的平均抑菌率为99.95%,有较强抑菌作用。
试验5皮肤刺激试验
动物:普通级新西兰兔3只,雄性。
环境条件:普通级动物房,室温 20℃~25℃;相对湿度41%~69%。
试验方法:
备皮:在染毒前24h,用除毛剂将家兔背部脊柱两侧腹部皮肤去掉,不得损伤皮肤。去毛面范围左右各不小于3cm×3cm。
染毒方法:采用同体左右侧自身对比法,将0.5g的样品直接均匀涂在面积为2.5cm×2.5cm 的左侧去毛完整皮肤上,然后用一层无刺激性的玻璃纸覆盖,再用无刺激胶布固定。右侧皮肤同法给予0.5ml氯化钠注射液作为阴性对照组。贴敷时间为4h,结束后用温水轻轻清洗染毒部位,并用吸水纸拭去残留水渍。每天涂抹一次,连续涂抹14d。
症状观察:在每次涂抹后24h 观察结果,按表7评分。为了便于受试物的涂抹和结果观察,必要时应剪毛。对照区的处理方法同试验区。
按下列公式计算每天每只动物平均积分(刺激指数),并以表8判定皮肤刺激强度。
测试结果见下表9。
结果:实验动物在染毒14天内染毒侧及对照侧皮肤未见任何皮肤红斑及水肿症状出现,每天每只动物染毒侧和对照测的平均积分均为0分。
结论:样品对家兔皮肤的刺激强度属无刺激性。
试验例6 本发明驱蚊效果实验
试验样品:批号20200313-2。
对照组样品:纯化水。
实验蚊虫:白纹伊蚊;饲养条件:温度(26±1)℃,相对湿度为(65±5)%,
实验方法:选取50位志愿者,随机分为10组,取人手背部5cm×5cm皮肤面积,掩盖其余皮肤,在其左手暴露的皮肤上涂抹0.25ml/cm2剂量的试验样品,涂抹后10min,将手伸进笼中停留100s,每间隔2 h测试1次,共测试4次,根据白纹伊蚊在手臂上的停留数,计算有效保护率(%),其中:有效保护率(%)=(对照组停落蚊虫数-实验组停落蚊虫数)/对照组停落蚊虫数×100%,结果见表10所示:
结果:由表10结果可知,试验样品4小时以内的有效保护率为81.2%,驱蚊效果显著。
试验7:有效成分稳定性试验
试验样品:醋酸氯己定;
批号: 20200310-1,20200310-2,20200310-3,20200310-4,20200313-1,20200313-2
试剂:乙腈,磷酸,磷酸二氢钾溶液
仪器:1,天平,2,pH计,3高效液相色谱仪,4稳定性试验箱SHH-500SD
色谱条件:流动相:磷酸二氢钾:乙腈=650:350;柱温,30℃、检测波长:254nm、进样量:10ul、色谱柱:C18柱(150mm×4.6mm ×5μm)、流量:1.0 ml /min。
试验样品:抑菌凝胶,批号20200310-1,20200313-2,20200313-2
放置条件:温度37℃,放置90d
结果:见表11。
结论:上述6个批号的消毒成分含有亚甲蓝成分含量下降率均未超过10%,实验结果显示,亚甲蓝成分对消毒稳定性有明显促进作用。
Claims (3)
1.一种防蚊消毒剂,其特征是:醋酸氯己定1~2份;维生素B5 2~4份;紫草提取物10~20份;薰衣草油5~10份;香茅精油1~2份;茶树油1~2份;维生素E 10~20份;无水乙醇 80~160份;甘油 60~120份;吐温80 10~20份;水800~1600份;亚甲基蓝0.008~0.016份;HPMC 20~40份混合均匀即得。
2.权利要求1所述的一种防蚊消毒剂,其特征是:醋酸氯己定1份;维生素B5 2份;紫草提取物10份;薰衣草油5份;香茅精油1份;茶树油1份;维生素E 10份;无水乙醇 80份;甘油60份;吐温80 10份;水800份;亚甲基蓝0.01份;HPMC 20份。
3.权利要求1或2所述的一种防蚊消毒剂,其特征是:防蚊消毒剂制备方法为:1)先在搅拌锅里加入去离子水,称量处方量亚甲基蓝溶液,加入醋酸氯己定、维生素B5搅拌至溶解,配成水相;2)称量处方量甘油、无水乙醇、吐温80、紫草提取物、茶树油、香茅精油、薰衣草油、VE搅拌至溶解,配成醇相;3)称取处方量HPMC,加入搅拌中的醇相,搅拌15分钟;4)将水相经过过滤后加入搅拌中的醇相,持续15分钟;5)搅拌混合样品经过-0.07Mpa真空乳化1小时,过滤灌装即为成品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010648737.XA CN111920911B (zh) | 2020-07-08 | 2020-07-08 | 一种防蚊消毒剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010648737.XA CN111920911B (zh) | 2020-07-08 | 2020-07-08 | 一种防蚊消毒剂及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111920911A CN111920911A (zh) | 2020-11-13 |
CN111920911B true CN111920911B (zh) | 2022-02-25 |
Family
ID=73312240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010648737.XA Active CN111920911B (zh) | 2020-07-08 | 2020-07-08 | 一种防蚊消毒剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111920911B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113440441B (zh) * | 2021-07-29 | 2022-09-16 | 山东福瑞达生物股份有限公司 | 一种含精油的口腔抑菌组合物及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006010269A1 (en) * | 2004-07-29 | 2006-02-02 | Robert Alan Reeve | Antimicrobial and/or antiviral composition and to methods for preparing and administering same |
CN101808627A (zh) * | 2007-08-24 | 2010-08-18 | 英赛特保健有限公司 | 抗菌剂 |
CN105456548A (zh) * | 2015-12-11 | 2016-04-06 | 郭健 | 一种医用泡沫消毒剂及其制备工艺 |
CN108935547A (zh) * | 2017-05-22 | 2018-12-07 | 陆文奎 | 天然驱蚊液 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105148059A (zh) * | 2015-08-28 | 2015-12-16 | 吉林大学 | 一种用于驱蚊虫的植物油复方外用擦剂及其制备方法 |
-
2020
- 2020-07-08 CN CN202010648737.XA patent/CN111920911B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006010269A1 (en) * | 2004-07-29 | 2006-02-02 | Robert Alan Reeve | Antimicrobial and/or antiviral composition and to methods for preparing and administering same |
CN101808627A (zh) * | 2007-08-24 | 2010-08-18 | 英赛特保健有限公司 | 抗菌剂 |
CN105456548A (zh) * | 2015-12-11 | 2016-04-06 | 郭健 | 一种医用泡沫消毒剂及其制备工艺 |
CN108935547A (zh) * | 2017-05-22 | 2018-12-07 | 陆文奎 | 天然驱蚊液 |
Also Published As
Publication number | Publication date |
---|---|
CN111920911A (zh) | 2020-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109316536A (zh) | 一种皮肤黏膜消毒剂及其制备方法 | |
CN101214355A (zh) | 一种复方丁香酚纳米乳组合物及其制备方法 | |
CN113081928A (zh) | 一种植物抑菌凝胶及其制备方法和应用 | |
CN108420789B (zh) | 一种苯扎氯铵外用溶液及其制备方法 | |
CN113631155A (zh) | 消毒剂组合物、其制备方法和用途 | |
CN101543658B (zh) | 防治宫颈糜烂的宫颈帽及其制备方法 | |
CN116367845A (zh) | 高浓度分子碘组合物,药物制剂,制备和用途 | |
CN111920911B (zh) | 一种防蚊消毒剂及制备方法 | |
WO2008104076A1 (en) | Electrocolloidal silver and echinacea root antimicrobial formulation | |
CN108404111A (zh) | 一种以芸豆植物凝集素为主要成分的抑菌抗病毒制剂 | |
CN1524587A (zh) | 茶树油抗菌、抑菌护理湿巾及制造方法 | |
CN111973551A (zh) | 一种贻贝粘蛋白抑菌凝胶及其制备方法 | |
CN106109588A (zh) | 一种治疗脚气的喷剂及其制备方法 | |
CN113101263A (zh) | 一种皮肤消毒微乳凝胶及其制备方法 | |
CN110664745A (zh) | 一种溶液制剂及其制备方法 | |
CN111248235A (zh) | 一种可杀灭冠状病毒的中西药复配消毒/抑菌剂及制备方法 | |
CN107737131A (zh) | 一种皮肤黏膜损伤抑菌消毒剂及制备方法 | |
CN114129493B (zh) | 一种天麻免洗抑菌凝胶及其制备方法和应用 | |
RU2203035C1 (ru) | Фармацевтическая композиция с дезинфицирующими, спороцидными и ранозаживляющими свойствами | |
CN115777725B (zh) | 一种纳米银消毒剂及其制备方法 | |
CN112972516B (zh) | 一种用于外耳道炎的消毒产品 | |
RU2391821C2 (ru) | Терапевтическое средство "фузобаквелт" на основе наносомной субстанции | |
JP2017203024A (ja) | 皮膚外用剤 | |
CN106389271A (zh) | 一种护肤抗菌液及其制备方法与应用 | |
CN114631538A (zh) | 大熊猫圈舍用消毒剂、制备方法及消毒方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |